Jim Cramer says that in the heart of earnings season, Wall Street analysts can make important calls that let bulls push stocks higher.

Jim Cramer takes a look at Berkshire Hathaway, Seattle Genetics, Zynerba Pharmaceuticals, Range Resources, Guardant Health, Danaher and more.

A stronger dollar put pressure on oil early Friday morning, sending the commodity temporarily off record gains hit earlier in the week, and analysts are fearful price volatility such as this will be the theme of 2018.

Here's what you need to know now for Thursday, Feb. 1.

Don't write off the worst stocks in the S&P 500 from 2017 just yet.

Despite soft jobs numbers, there's a whole tape of hot new winners in this market, says Jim Cramer. Here's next week's game plan.

Market strategy and sector research firm Fundstrat noted on Tuesday several energy stocks investors should be keen on as oil prices rebound.

Energy is a key driver of value recovery, Fundstrat says. These stocks in the energy space deserve attention.

A top expert on the space weighs in.

The renowned investor wants to end a habit that is part of his legend.

Something that has never been legal -- even in Sin City -- is coming to a major location just off the Las Vegas Strip.

The Wall Street Journal reported Tuesday that a panel advising the European Data Protection Board has raised concerns over Meta's targeted ad sales.